It's no secret that these are tough times for orthopedic companies. But Stephen MacMillan, president/CEO and chairman of Stryker (Kalamazoo, Michigan) says the not-so-optimistic outlook for the orthopedic market – an area Stryker is known for – is "not at all" a reason the company has agreed to acquire the assets of the Neurovascular division of Boston Scientific (Natick, Massachusetts). (Medical Device Daily) Read More
